Related Experiment Video
Updated: May 24, 2025

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
Bronchoscopic valve therapy for tuberculosis: a scoping review
Kshitij Agarwal1, Adam T Gray2, Tudor P Toma2
1Department of Pulmonary and Critical Care Medicine, Delhi Hospital, Bahadurgarh.
Endobronchial valves show promise for closing tubercular cavities in multidrug-resistant tuberculosis (MDR-TB) patients, improving outcomes. Further international trials are needed to confirm efficacy and develop affordable devices for wider use.
Area of Science:
- Pulmonology
- Infectious Diseases
- Medical Devices
Background:
- Multidrug-resistant tuberculosis (MDR-TB) management is challenging, especially with TB-HIV co-infection.
- Traditional surgical methods for TB are largely replaced by antibiotics.
- Endobronchial interventions, like valves, are emerging as potential adjunctive therapies for MDR-TB.
Purpose of the Study:
- To review the feasibility of using endobronchial valves for tubercular cavity closure.
- To assess the impact of endobronchial valves on clinical outcomes and sputum smear conversion in MDR-TB patients.
Main Methods:
- A literature search was conducted on PubMed from inception to September 2024.
- Review of small studies investigating endobronchial valve use for TB cavity closure.
Main Results:
- Small studies indicate that endobronchial valves can feasibly close tubercular cavities.
- Valve use demonstrated improved clinical outcomes and sputum smear conversion in reviewed studies.
Conclusions:
- Endobronchial valves show potential for treating MDR-TB by facilitating cavity closure.
- Limited access to approved valves and funding impede large-scale trials.
- International collaboration and innovation are crucial for further research and development of cost-effective devices for MDR-TB patients, particularly in low-income settings.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pneumothorax-II
Clinical Manifestations:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Endoscopic Studies I: Bronchoscopy and Thoracoscopy
Bronchoscopy
Description
Bronchoscopy is a procedure that involves direct visualization of the larynx, trachea, and bronchi for diagnostic and therapeutic purposes. A flexible fiber optic or rigid bronchoscope is used to carry out the procedure. The fiber-optic bronchoscope is more frequently used due...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

